JustineYangBruceMD

Oncology • Madison, WI

Head & Neck Cancer, Hematologic Oncology, Hospice & Palliative

Associate Professor, Department of Medicine, University of Wisconsin

Join to view full profile

Dr. Bruce is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bruce's full profile

Already have an account?

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-265-1700

Fax+1 608-265-4452

Summary

Dr. Justine Bruce is an oncologist in Madison, WI and is affiliated with multiple hospitals in the area, including University Hospital and William S. Middleton Memorial Veterans Hospital. She received her medical degree from University of Texas Southwestern Medical School and has been in practice 15 years. She specializes in head & neck cancer, hematologic oncology, and hospice & palliative and is experienced in hospice and palliative medicine, head and neck oncology, clinical research, and drug development.

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 2005 - 2008
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2002 - 2005
University of Texas Southwestern Medical SchoolClass of 2002

Certifications & Licensure

TX State Medical License 2004 - 2025
WI State Medical License 2008 - 2025
IL State Medical License 2005 - 2014
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer Start of enrollment: 2011 Feb 01
Unknown status
Phase 2
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer Start of enrollment: 2012 Feb 01
Terminated
Phase 2
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis Start of enrollment: 2013 May 01
Terminated
Phase 2
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors Start of enrollment: 2014 Sep 01
Completed
Phase 1
Cetuximab in Head and Neck Cancer Patients Start of enrollment: 2019 Apr 17
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-cen...
Justine Yang Bruce, Adam Burr, Randall J Kimple, David P Adam, Menggang Yu
Ebiomedicine. 2024-12-12
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.
Paul L Swiecicki, Emrullah Yilmaz, Ari Joseph Rosenberg, Takao Fujisawa, Justine Yang Bruce
Journal of Clinical Oncology. 2024-10-31
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.
Bridget E Crossman, Regan L Harmon, Kourtney L Kostecki, Nellie K McDaniel, Mari Iida
Journal of Clinical Medicine. 2024-10-10

Press Mentions

UW Prostate Cancer Physician Earns Young Investigator AwardJune 30th, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member